The effects of N-methyl-D-aspartate (NMDA) and its competitive antagonist, 3-(2-carboxypiperazine-4-yl) propyl-1-phosphonic acid (CPP), injected into caudate-putamen on kindled amygdaloid seizures in rats

Brain Research

Volumn 728, Issue 2, 1996, Pages 242-246

  Osonoe, Minako ^a   Mori, Norio ^a   Hoshino, Shuzo ^a   Yamada, Yasuhito ^a   Osonoe, Kouichi ^a   Kittaka, Hajime ^a   Iwata, Yasuhide ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

3 (2 Carboxypiperazine 4 yl)propyl 1 phosphonic acid; Amygdala; Caudate putamen; Cerebral cortex; Kindling; N Methyl D aspartate; Substantia nigra; Thalamus

Indexed keywords

4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CAUDATE NUCLEUS; CONTROLLED STUDY; HISTOLOGY; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; SEIZURE; SUBSTANTIA NIGRA; THALAMUS NUCLEUS;

EID: 0030605875     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00412-X     Document Type: Article

References (24)

1. [1] Aiko, Y., Hosokawa, S., Shima, F., Kato, M. and Kitamura, K., Alteration in local cerebral glucose utilization during electrical stimulation of the striatum and globus pallidus in rats, Brain Res., 442 (1988) 43-52.
2. [2] Bradford. H.F. and Dodd, P.R., Biochemistry and basic mechanisms in epilepsy. In A.N. Davison (Ed.), Biochemistry and Neurological Disease, Blackwell Press, Oxford, 1976, pp. 114-168.
3. [3] Carpenter, M.B., Anatomical organization of the corpus striatum and related nuclei. In M.D. Yahr (Ed.), The Basal Ganglia, Raven Press, New York, 1976, pp. 1-35.
4. [4] Cavalheiro, E.A., Bortolotto, Z.A. and Turski, L., Microinjections of the γ-aminobutyrate antagonist, bicuculline methiodide, into the caudate-putamen prevent amygdala-kindled seizures in rats, Brain Res., 411 (1987) 370-372.
5. [5] Cavalheiro, E.A. and Turski, L., Intrastriatal N-methyl-D-aspartate prevents amygdala kindled seizures in rats, Brain Res., 377 (1986) 173-176.
6. [6] Chevalier, G. and Deniau, J.M., Disinhibition as a basic process in the expression of striatal functions, Trends Neurosci., 13 (1990) 277-280.
7. [7] Corcoran, M.E., Urstad, H., McCaughran, J.A. Jr. and Wada, J.A., Frontal lobe kindling in the rat, Can. J. Neurol Sci., 2 (1975) 501-508.
8. [8] Costa, E., Guidotti, A. and Toffano, G., Molecular mechanisms mediating the action of diazepam on GABA receptors, Br. J. Psychiatry, 133 (1978) 239-248.
9. [9] Croucher, M.J., Collins, J.F. and Meldrum, B.S., Anticonvulsant action of excitatory amino acid antagonists, Science, 216 (1982) 899-901.
10. [10] Gale, K. and Casu, M., Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications, Mol. Cell Biochem., 39 (1981) 369-405.
11. [11] Hiyoshi, T. and Wada, J.A., Midline thalamic lesion placement prior to kindling, Electroencephalogr. Clin. Neurophysiol., 70 (1989) 325-338.
12. [12] Holmes, K.H., Bilkey, D.K., Laverty, R. and Goddard, G.V., The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures, Brain Res., 506 (1990) 227-235.
13. [13] Kalichman, M.W., Pharmacological investigation of convulsant γ-aminobutyric acid (GABA) antagonists in amygdala-kindled rats, Epilepsia, 23 (1982) 163-171.
14. [14] Kelly, P.A.T. and McCulloch, J., Cerebral glucose utilization following striatal lesions: the effects of the GABA agonist, muscimol, and the dopaminergic agonist, apomorphine, Brain Res., 425 (1987) 290-300.
15. [15] Lscher, W. and Schwark, W., Further evidence for abnormal GABAergic circuits in amygdala-kindled rats, Brain Res., 420 (1987) 385-390.
16. [16] Macdonald, R.L. and Bergey, G.K., Valproic acid augments GABA-mediated postsynaptic inhibition in cultured mammalian neurons, Brain Res., 170 (1979) 558-562.
17. [17] McNamara, J.O., Galloway, M.T., Rigsbee, L.C. and Shin, C., Evidence implicating substantia nigra in regulation of kindled seizure threshold, J. Neurosci., 4 (1984) 2410-2417.
18. [18] Meldrum, B.S., Amino acid neurotransmitters and new approaches of anticonvulsant drug action, Epilepsia, 25 (Suppl. 2) (1984) S140-S149.
19. [19] Mori, N. and Watanabe, M., Comparison of effects of bilateral injections of bicuculline and muscimol into the caudate-putamen of amygdaloid-kindled rats, Neurosci. Lett., 169 (1994) 129-132.
20. [20] Murphy, D.E., Schneider, J., Boehm, C., Lehmann, J. and Williams, M., Binding of [3H]3-(2-carboxypiperazine-4-yl)propyl-1-phosphonic acid to rat brain membranes: A selective, high-affinity ligand for N-methyl-D-aspartate receptors, J. Pharmacol Exp. Ther., 240 (1987) 778-784.
21. [21] Psatta, D.M., Control of chronic experimental focal epilepsy by feedback caudatum stimulations, Epilepsia, 24 (1983) 444-454.
22. [22] Racine, R.J., Modification of seizure activity by electrical stimulation. II. Motor seizure, Electroencephalogr. Clin. Neurophysiol., 32 (1972) 269-279.
23. [23] Sato, M., Functional changes in the caudate and accumbens nuclei during amygdaloid and hippocampal seizure development in kindled cats, Folia Psychiatr. Neurol. Jpn., 31 (1977) 501-512.
24. [24] Steriade, M. and Deschenes, M., The thalamus is a neuronal oscillator, Brain Res. Rev. 8 (1984) 1-63.